REPLIGEN CORP (RGEN) Nonoperating Income (Expense) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Repligen Corp quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2024.
  • Repligen Corp Nonoperating Income (Expense) for the quarter ending March 31, 2024 was $83 K, a 98.3% decline year-over-year.
  • Repligen Corp Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was $4.8 M, a 1181% increase year-over-year.
  • Repligen Corp annual Nonoperating Income (Expense) for 2023 was $9.56 M.
  • Repligen Corp annual Nonoperating Income (Expense) for 2022 was -$5.53 M, a 59.7% increase from 2021.
  • Repligen Corp annual Nonoperating Income (Expense) for 2021 was -$13.7 M, a 29.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.8 M $83 K -$4.75 M -98.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $9.56 M -$7.87 M -$12 M -290% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $21.6 M $6.83 M +$12 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $9.55 M $5.76 M +$9.17 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $375 K $4.84 M +$5.91 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$5.53 M $4.15 M +$6.73 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$12.3 M -$5.2 M -$1.24 M -31.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$11 M -$3.41 M +$470 K +12.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$11.5 M -$1.07 M +$2.21 M +67.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$13.7 M -$2.58 M +$57 K +2.16% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$13.8 M -$3.96 M -$744 K -23.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$13 M -$3.88 M -$365 K -10.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$12.7 M -$3.28 M -$2.05 M -167% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 -$10.6 M -$2.64 M -$1.09 M -70.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 -$9.51 M -$3.22 M +$3.08 M +48.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$12.6 M -$3.52 M -$2.08 M -145% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-27
Q1 2020 -$10.5 M -$1.23 M -$575 K -87.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$9.93 M -$1.55 M -$566 K -57.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 -$9.37 M -$6.29 M -$5.03 M -398% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$4.34 M -$1.44 M -$529 K -58.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 -$3.81 M -$655 K +$745 K +53.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$4.55 M -$983 K Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 -$1.26 M +$353 K +21.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 -$906 K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$1.4 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 -$1.62 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.